National Bank of Canada’s AbbVie ABBV Stock Holding History

National Bank of Canada’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65.4M	Buy	2,600 +1,350	+108%	+$290K	0.05%	293
2026 Q1	$27.2M	Buy	1,250 +650	+108%	+$144K	0.02%	413
2025 Q4	$13.7M	Sell	600 -395	-40%	-$90K	0.01%	632
2025 Q3	$23M	Sell	995 -1,005	-50%	-$205K	0.02%	460
2025 Q2	$37.1M	Sell	2,000 -1,050	-34%	-$195K	0.04%	365
2025 Q1	$63.9M	Buy	+3,050	New	+$593K	0.07%	255
2024 Q3	–	Sell	-3,000	Closed	-$51.1M	–	2726
2024 Q2	$51.1M	Buy	3,000 +920	+44%	+$152K	0.07%	222
2024 Q1	$33.4M	Buy	+2,080	New	+$358K	0.05%	293
2023 Q4	–	Sell	-1,406	Closed	-$20.8M	–	2705
2023 Q3	$20.8M	Buy	+1,406	New	+$206K	0.03%	404

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

National Bank of Canada's ABBV Position: Q2 2026 in Review

National Bank of Canada reduced its AbbVie (ABBV) stake by 8.2% in Q2 2026, selling an estimated $16.4M and leaving 850,973 shares worth $214M. The position accounts for 0.15% of the portfolio, ranked #121.

National Bank of Canada first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $442M in Q3 2025. 3,392 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

National Bank of Canada held 850,973 shares of AbbVie worth $214M as of Q2 2026.
National Bank of Canada sold 76,163 AbbVie shares in Q2 2026, an estimated $16.4M.
AbbVie made up 0.15% of National Bank of Canada's portfolio in Q2 2026, its #121 holding.
National Bank of Canada first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
National Bank of Canada's AbbVie position peaked at $442M in Q3 2025.
3,392 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.